Currently holding the Bristol Myers Squibb Endowed Chair in Chemistry at Scripps Research, along with the Frank and Bertha Hupp Professorship, Yu is a vanguard in developing novel methodologies for molecular construction with unrivaled precision. His research primarily focuses on the direct activation and modification of C–H bonds, a paradigm shift from traditional synthetic routes that require multiple steps and functional group manipulations. By targeting the ubiquitous yet inert C–H bonds, Yu’s approach significantly streamlines chemical synthesis, potentially revolutionizing pharmaceutical and material chemistry.

C–H activation has historically posed a formidable challenge due to the robust nature and prevalence of C–H bonds in organic molecules. Yu’s strategic development of highly selective catalysts has enabled chemists to perform site-specific transformations, a feat that offers unprecedented control over molecular architecture. His groundbreaking designs of chiral catalysts have further empowered the synthesis of enantioenriched compounds—those with a unique “handedness” crucial for biological activity and drug efficacy.

The significance of chirality in pharmaceuticals cannot be overstated; the bioactive conformation of a molecule often dictates its therapeutic potency and safety profile. Yu’s pioneering work in enantioselective C–H activation addresses this by enabling the direct formation of chiral centers without the need for pre-functionalized substrates, thus enhancing synthetic efficiency and sustainability. His achievements in this arena are exemplified by the first generation of chiral catalysts that possess the remarkable ability to discriminate between enantiotopic C–H bonds in complex molecules.

Among Yu’s recent breakthroughs is the innovative utilization of inexpensive fluoride salts combined with unconventional catalysts to achieve selective C–H bond modification, as delineated in his 2024 Nature publication. This methodology opens new avenues for late-stage functionalization of drug candidates and radiotracers for advanced medical imaging, providing both cost-effectiveness and improved synthetic routes for complex molecules. Such techniques hold significant promise for accelerating drug discovery pipelines and fine-tuning pharmacological properties.

Yu’s research extends beyond hydrocarbons; he has successfully expanded C–H activation methodologies to oxygenated substrates such as alcohols, broadening the scope and utility of this powerful synthetic tool. His team’s latest endeavors also include pioneering activation protocols for ketones and esters, classes of compounds ubiquitously encountered in organic synthesis and natural products, thereby unlocking new chemoselective transformations.

In addition to functionalizing acyclic compounds, Yu has devised streamlined strategies for constructing saturated heterocycles, which are integral frameworks in the majority of FDA-approved drugs. These saturated rings, composed of nitrogen, oxygen, or sulfur atoms, contribute significantly to the pharmacokinetic and pharmacodynamic profiles of therapeutic agents. Yu’s methodologies offer scalable and straightforward access to these biologically relevant scaffolds, fostering innovation in medicinal chemistry.

Throughout his prolific career, Yu has garnered multiple accolades reflecting his stature in the chemistry community. His honors include the coveted Akira Suzuki Award, the Chemical Pioneer Award from the American Institute of Chemists, and the Henry J. Albert Award bestowed by the International Precious Metals Institute. He has also been recognized with Harvard University’s Max Tishler Prize, the University of Tokyo’s Yamada-Koga Prize, and a MacArthur Fellowship—often dubbed the “genius grant”—which celebrates exceptional creativity in scientific research. His election to both the National Academy of Sciences and the American Academy of Arts and Sciences further cements his role as a leading figure shaping the future of chemistry.

The induction into the Royal Society is accompanied by a series of scholarly activities, including a seminar where new fellows present their scientific contributions, and a formal admissions ceremony where Yu will inscribe his name in the Royal Society’s historic Charter Book. This fellowship not only honors Yu’s scientific achievements but also strengthens international collaborations that drive innovation for societal benefit.

Scripps Research continues to be at the forefront of biomedical innovation, with an interdisciplinary environment that nurtures breakthroughs from discovery to application. Its drug discovery division, Calibr-Skaggs, stands as a beacon of translational science, working collaboratively to expedite the journey of novel therapeutics to patients. Simultaneously, the Scripps Research Translational Institute integrates advanced genomics and digital medicine to pioneer personalized healthcare strategies, highlighting the institute’s commitment to revolutionizing modern medicine through cutting-edge science.

Beyond research, Scripps Research is acclaimed for its exceptional graduate program, consistently ranked among the top ten in the United States for chemistry and biological sciences. Under distinguished faculty leadership, including scholars like Jin-Quan Yu, the institute cultivates the next generation of scientific leaders equipped to tackle complex challenges in health and disease. This confluence of innovation, education, and collaboration underscores Scripps Research’s pivotal role in shaping the future of science and medicine globally.

The election of Jin-Quan Yu to the Royal Society not only celebrates his personal achievements but also symbolizes the transformative potential of C–H activation chemistry to revolutionize molecular synthesis. His visionary work exemplifies how fundamental research can lead to novel methodologies with widespread implications—from designing more efficient synthetic routes to enabling precision medicine. As these catalytic technologies continue to evolve, they promise to accelerate discovery and enhance the ability of chemists to create molecules with unprecedented complexity and functionality.

Subject of Research: Asymmetric carbon–hydrogen (C–H) activation and enantioselective catalysis in synthetic organic chemistry

Article Title: Professor Jin-Quan Yu Elected Fellow of the Royal Society for Groundbreaking Advances in C–H Activation Chemistry

News Publication Date: December 2025

Web References:
– https://www.scripps.edu/faculty/yu/
– https://www.scripps.edu/news-and-events/press-room/2025/20251211-yu-nature-fluorine.html
– https://www.scripps.edu/news-and-events/press-room/2023/20230906-yu-nature.html
– https://www.scripps.edu/news-and-events/press-room/2025/20250108-yu-keytone-ester.html
– https://www.scripps.edu/news-and-events/press-room/2024/20240411-yu-saturated-hetrocycles.html

Image Credits: Scripps Research

Keywords

Asymmetric C–H activation, chiral catalysis, enantioselective synthesis, synthetic organic chemistry, catalyst design, molecular modification, pharmaceuticals, C–H bond functionalization, saturated heterocycles, medicinal chemistry, catalytic fluorination, ketone activation, ester activation

Yu’s pioneering work centers on the activation and selective transformation of carbon–hydrogen (C–H) bonds, which are ubiquitous yet notoriously inert within organic molecules. The challenge of selectively manipulating these bonds has long stymied chemists, as they are both prevalent and chemically resilient, often requiring harsh or inefficient methods for functionalization. Yu’s research represents a transformative advance by devising catalysts that precisely target these bonds, enabling the construction of complex molecular architectures with unprecedented control and efficiency.

One of the most celebrated aspects of Yu’s work is his development of the first chiral catalysts capable of enantioselective C–H bond activation. This breakthrough allows for the creation of single-handed molecules—molecules that exist in only one enantiomeric form—which is of tremendous importance in fields such as pharmaceuticals where molecular handedness can determine the efficacy and safety of a drug. This innovation fundamentally changes the landscape of synthetic methodology by providing a versatile approach to generate complex chiral molecules more directly and with fewer synthetic steps.

Beyond the fundamental chemistry, Yu’s research has practical implications across a broad spectrum of scientific disciplines including medicinal chemistry, agriculture, and materials science. By facilitating the selective modification of C–H bonds, his catalysts enable the streamlined synthesis and modification of molecules that could be used in drug discovery, crop protection agents, and advanced materials with novel properties. These applications highlight the pervasive impact of Yu’s innovations on both fundamental science and technological development.

Recent work emerging from Yu’s laboratory has pushed these boundaries further, featuring a novel catalytic method that combines innovative ligands with inexpensive and readily available fluoride salts to activate some of the most common and inert chemical bonds. This method not only makes chemical transformation more economically viable but also opens new avenues for the synthesis of molecules relevant to medical imaging and diagnostics, potentially revolutionizing ways in which diseases are detected and monitored.

The significance of Yu’s contributions has been recognized through numerous accolades. Among them, the Akira Suzuki Award honors his creative achievements in chemical synthesis, while the American Chemical Society’s Award for Creativity in Molecular Design and Synthesis recognizes his inventive approach to catalyst development. Furthermore, his election to the American Academy of Arts and Sciences and receipt of a MacArthur Fellowship affirm the wide esteem that the scientific community holds for his work.

At Scripps Research, Yu holds the prominent Bristol Myers Squibb Endowed Chair in Chemistry, as well as the Frank and Bertha Hupp Professorship in Chemistry, roles which enable him to push the envelope of chemical research and mentor the next generation of scientists. His laboratory is a hub of innovation, consistently producing research that challenges established paradigms and offers new synthetic pathways previously thought unattainable.

The methodology that Yu has pioneered is a paradigm shift in C–H activation chemistry, transforming what was once an intractable problem into a versatile tool for molecular design. By harnessing the properties of novel catalysts and optimizing reaction conditions for selectivity and enantioselectivity, his approach allows organic chemists to access regions of chemical space that were previously inaccessible, thereby accelerating the discovery of new molecules and materials.

This election to the National Academy of Sciences comes at a time when the chemical sciences are rapidly evolving, with increasing demands for sustainable, efficient, and selective synthetic methods. Yu’s work addresses these demands head-on, providing novel solutions that are both elegant and practical. His strategies contribute not only to the fundamental understanding of C–H bond reactivity but also bolster the toolkit available for chemists working on real-world challenges.

The broader scientific and medical communities stand to benefit immensely from Yu’s breakthroughs, as these catalytic methods can streamline the synthesis of drugs, improve the precision of molecular probes, and enhance the development of functional materials. This cross-disciplinary relevance exemplifies the profound societal impact of advanced chemical research when coupled with visionary scientific inquiry.

Yu’s election to the NAS not only celebrates his past achievements but also raises expectations for future discoveries from his lab. As he continues to refine catalytic systems and explore novel chemical reactivities, the potential to unlock new molecular complexities and functionalities remains vast. This honors both Yu’s scientific excellence and his commitment to pushing the boundaries of synthetic chemistry.

In sum, Jin-Quan Yu’s election to the National Academy of Sciences is a testament to his status as a pioneering force in synthetic organic chemistry. Through the inventive design of chiral catalysts enabling selective C–H bond activation, he has opened new frontiers in molecular synthesis with broad-ranging implications for science and society. His work embodies the spirit of innovation and the transformative power of chemistry in understanding and manipulating the molecular world.

Subject of Research: Synthetic Organic Chemistry, Carbon–Hydrogen Bond Activation, Enantioselective Catalysis

Article Title: Jin-Quan Yu Elected to the National Academy of Sciences for Groundbreaking Advances in C–H Bond Activation

News Publication Date: Not provided

Web References:
https://www.scripps.edu/faculty/yu/
https://www.scripps.edu/news-and-events/press-room/2025/20251211-yu-nature-fluorine.html
http://www.scripps.edu

Image Credits: Scripps Research

Keywords

Carbon–Hydrogen Bond Activation, Enantioselective Catalysis, Synthetic Organic Chemistry, Chiral Catalysts, Molecular Synthesis, Jin-Quan Yu, National Academy of Sciences, Catalysis Innovation, Pharmaceutical Chemistry, Chemical Bond Functionalization

Amines serve as foundational building blocks across a vast spectrum of bioactive compounds, underpinning pharmaceuticals, agrochemicals, and organic materials. Despite their prevalence, the chemical transformation of aromatic amines, particularly the cleavage and substitution of the aromatic C–N bond, has traditionally hinged on forming diazonium salts. Although effective, diazonium intermediates are notoriously unstable and pose severe explosion risks, complicating their practical application and scalability in both academic and industrial settings.

Addressing these longstanding limitations, the research team has introduced a direct deaminative functionalization strategy employing N-nitroamines as pivotal intermediates. This innovative pathway enables chemists to bypass the hazardous diazonium salts entirely, directly converting relatively inert aromatic C–N bonds into a remarkable variety of carbon–heteroatom and carbon–carbon linkages. The spectrum of accessible products now includes C–Br, C–Cl, C–I, C–F, C–N, C–S, C–Se, C–O, and various C–C bonds, markedly expanding synthetic versatility under mild and operationally straightforward conditions.

One of the most compelling features of this approach lies in the unification of cross-coupling methodologies, whereby the formation of N-nitroamines seamlessly integrates with transition-metal-catalyzed arylation reactions within a single synthetic operation. This one-pot strategy not only economizes time and resources but also simplifies complex synthetic routes, a boon for late-stage functionalization where subtle molecular modifications can have profound effects on biological activity and material properties.

The robustness of this new method is demonstrated across an astonishingly broad chemical landscape. It efficiently modifies a wide array of medicinally relevant heteroaromatic amines and structurally diverse aniline derivatives. Importantly, the process proves largely indifferent to the electronic nature of the substrates and the specific positioning of the amino group on the aromatic ring, underscoring its generality and potential to revolutionize functionalization approaches for complex molecules.

Mechanistic insights gleaned from complementary experimental observations and computational analyses reveal that the reactivity of the N-nitroamine intermediates is best rationalized through an aryl cation equivalent paradigm. This electrophilic character enables the intermediates to act as versatile synthetically useful intermediates under mild conditions, facilitating substitution pathways that have traditionally been challenging under conventional diazonium chemistry.

From a safety perspective, the transition away from explosive aryldiazonium salts represents a paradigm shift within synthetic organic chemistry. The newfound stability and ease of handling associated with N-nitroamines reduce the inherent risks of traditional protocols, fostering safer laboratory environments and facilitating scale-up operations in industrial synthetic processes. This advance harmonizes the oft-conflicting priorities of synthetic efficiency, operational safety, and environmental consideration.

The researchers also highlight the synthetic applications that stand to benefit immensely from this technology. Late-stage functionalization—a critical step in drug development and lead optimization—can now be performed with greater confidence and flexibility, enabling fine-tuning of physicochemical and pharmacokinetic properties without compromising molecular integrity. This could accelerate the discovery pipeline and diversify the chemical space explored in medicinal chemistry campaigns.

Furthermore, the implementation of this method in constructing complex carbon–heteroatom linkages aligns with the growing importance of heteroatoms in imparting resilience, bioavailability, and specificity to therapeutic agents. The ability to selectively incorporate halogens or chalcogens into aromatic scaffolds improves binding interactions, modifies metabolic profiles, and enables downstream synthetic elaborations that are crucial to drug design.

In addition to pharmaceutical chemistry, the ramifications extend into materials science, where precisely functionalized aromatic compounds underpin the design of organic electronics, sensors, and catalysts. The broad substrate scope and modularity of the N-nitroamine-based transformations open avenues for rapid access to novel functionalized aromatic motifs, stimulating innovation across intersecting disciplines.

This pioneering work also raises exciting prospects for future research. The elucidation of reaction pathways and intermediate species enhances our fundamental understanding of aromatic substitution dynamics beyond classical frameworks. Such knowledge could inspire the development of even more sophisticated synthetic strategies, including enantioselective variants or site-selective modifications of polyfunctional substrates.

By integrating mechanistic rigor with practical utility, this study firmly establishes the deaminative functionalization via N-nitroamines as a transformative technology poised to replace diazonium-dependent methodologies. As the chemical community increasingly prioritizes safe, sustainable, and versatile synthetic methods, this innovation emerges as a shining exemplar of modern synthetic ingenuity.

Looking forward, it is anticipated that pharmaceutical chemists, synthetic organic specialists, and process scientists will enthusiastically adopt this approach, expanding its use beyond academic curiosity to industrial mainstay. The harmonization of operational simplicity, safety, and expansive functional group compatibility marks a new chapter in the synthesis of aromatic compounds.

The significance of this development transcends mere technique; it embodies the ethos of contemporary chemistry—embracing innovation to surmount longstanding barriers, enhancing molecular craftsmanship while prioritizing safety and environmental stewardship. The future synthesis landscape is indeed brighter and safer thanks to the visionary work on direct deaminative functionalization with N-nitroamines.

Subject of Research: Aromatic amine functionalization; deaminative cross-coupling; N-nitroamines; safer synthetic methodologies; transition-metal catalysis.

Article Title: Direct deaminative functionalization with N-nitroamines.

Article References:
Tu, G., Xiao, K., Chen, X. et al. Direct deaminative functionalization with N-nitroamines. Nature (2025). https://doi.org/10.1038/s41586-025-09791-5

Image Credits: AI Generated

Sulfonamides are among the foundational scaffolds in medicinal chemistry, valued for their broad biological activity and versatile physicochemical properties. Traditionally, synthesizing primary sulfonamides necessitates multiple preparative steps involving preactivation, often limiting rapid exploration of chemical space. The direct SO₂ insertion reported here circumvents these constraints by exploiting a unique reagent—a cleverly designed anomeric amide—that effectively flips the reactivity profile of nitrogen atoms. This inversion in nitrogen’s intrinsic characteristics—including acidity and hydrogen bonding capabilities—opens fresh avenues for molecular modification previously deemed challenging or impractical.

The essence of this transformation lies in the dual functionality of the anomeric amide reagent. Functioning not just as a passive coupling partner, the reagent actively orchestrates cleavage of the initial C–N bond while seamlessly integrating a nitrogen atom into the emerging sulfonamide structure. Such an elegant dual role removes the need for traditional prefunctionalization steps, which typically involve cumbersome activating groups and harsh reaction conditions, thereby greatly simplifying synthesis workflows. The net effect is a highly streamlined reaction pathway that is both practical and robust.

Importantly, the chemistry underpinning this SO₂ insertion is not just a simple substitution; mechanistic studies reveal a complex yet elegant radical chain pathway dominated by an isodiazene intermediate. This reactive species propagates a radical mechanism that initially cleaves the amine’s C–N bond and forms an intermediate sulfinate species. Following this, the anomeric amide intercepts the sulfinate to forge the sulfonamide’s characteristic S–N bond. This radical chain mechanism enhances the reaction’s efficiency and selectivity, which is crucial when working with sensitive functionalities common in drug-like molecules.

One of the transformative features of this protocol is its remarkable tolerance for diverse functional groups. Whether bearing electron-rich or electron-poor substituents, heterocycles, or delicate protecting groups, the reaction proceeds smoothly without compromising structural integrity. This broad substrate scope significantly expands the potential for late-stage functionalization, a critical paradigm in medicinal chemistry where complex molecules are modified at advanced stages to fine-tune biological properties and pharmacokinetics.

In addition to its synthetic versatility, the SO₂ insertion method is adaptable to automated platforms, marking a significant stride toward high-throughput experimentation (HTE). The ability to run the reaction under automated conditions accelerates the generation of sulfonamide libraries, enabling medicinal chemists to explore vast chemical space in a fraction of the time traditionally required. This feature is timely, given the pharmaceutical industry’s current emphasis on integrating automation and machine learning to improve drug discovery pipelines efficiently.

The implications for medicinal chemistry and drug development are profound. Sulfonamides are key motifs in numerous approved therapeutics, often contributing to crucial target engagements through hydrogen bonding or serving as metabolic blockers. By enabling direct synthesis of primary sulfonamides from readily available amines, this methodology unlocks a reservoir of previously inaccessible compounds. This could catalyze the discovery of novel drug candidates and facilitate the fine-tuning of existing leads, accelerating the trajectory from hit identification to clinical candidate.

To illustrate the practical utility of their chemistry, the authors applied the method across a diverse library of amines, demonstrating high conversion rates and compatibility with complex molecular architectures. The reaction’s amenability to late-stage modification was showcased by transforming active pharmaceutical ingredients (APIs), thus underpinning its potential for lead diversification and analog synthesis. The ability to enact net CO-to-SO₂ isosteric replacement further exemplifies the strategy’s power to effect subtle yet impactful molecular changes that can modulate bioactivity or pharmacokinetic properties.

The mechanistic foundation was rigorously probed through kinetic and spectroscopic investigations, which supported the proposed isodiazene radical chain pathway. This mechanistic clarity is not merely academic; it informs future reaction development and mechanistic tuning, allowing researchers to predict and control reactivity in complex settings. Understanding such radical pathways is particularly important as radical processes often possess distinct selectivities and functional group tolerance compared to classical polar mechanisms.

Beyond the laboratory bench, the integration of this chemistry into automated high-throughput platforms signals its potential for widespread adoption in medicinal chemistry workflows. Large-scale library diversification campaigns become feasible, enabling the parallel generation of sulfonamide analogs that can be rapidly screened for biological activity. Such integration aligns with the current trends toward miniaturization and automation in chemical synthesis, ensuring that this innovative transformation will find resonance well beyond academic curiosity.

In summary, the formal SO₂ insertion into C–N bonds represents a seminal advance in the toolbox available to medicinal chemists. By reimagining traditional approaches to sulfonamide synthesis and applying a strategically designed anomeric amide reagent, the researchers have unlocked a reaction that combines mechanistic elegance with practical utility. This development not only facilitates rapid access to a crucial pharmacophore but also embodies the convergence of synthetic ingenuity and automation that underpins modern drug discovery.

Looking forward, the potential to extend this methodology to other nitrogen-containing substrates and to harness related radical pathways for diverse bond constructions is vast. The platform lays the groundwork for future explorations into selective bond activations, potentially unlocking other “undruggable” chemical transformations that can impact the design of next-generation therapeutics. By bridging mechanistic insight with application-focused innovation, this work exemplifies how contemporary synthetic chemistry continues to drive progress in medicinal sciences.

This breakthrough is certain to inspire renewed interest in direct functionalization strategies and will likely spark a wave of research focusing on the design of multifunctional reagents capable of manipulating complex molecules with unprecedented precision. As the pharmaceutical landscape becomes increasingly intricate, such tools become invaluable for navigating the complexities of molecular optimization and therapeutic innovation.

The study reflects a broader scientific ethos: that modern challenges in chemistry often require a harmonious blend of thoughtful reagent design, deep mechanistic understanding, and an eye toward practical applicability. The researchers’ success in leveraging an anomeric amide as both a bond cleaving and bond forming agent is a testament to this integrated approach. It encapsulates the continual evolution of synthetic methodology toward more concise, efficient, and versatile chemical transformations.

In conclusion, the ability to access sulfonamides directly via formal SO₂ insertion into C–N bonds redefines how chemists can manipulate nitrogen-containing compounds. The method’s operational simplicity, broad tolerance, and mechanistic sophistication together set a new standard for functional group interconversions in medicinal chemistry. As such, it promises to become a linchpin technology, accelerating discovery and broadening horizons for drug development across academic and industrial spheres alike.

Subject of Research: Functional group interconversion via formal SO₂ insertion into C–N bonds for the synthesis of primary sulfonamides.

Article Title: Accessing sulfonamides via formal SO₂ insertion into C–N bonds.

Article References:
Kim, M., Obertone, C.E., Kelly, C.B. et al. Accessing sulfonamides via formal SO₂ insertion into C–N bonds. Nat. Chem. (2025). https://doi.org/10.1038/s41557-025-01848-2

Image Credits: AI Generated